Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Net Margin (2020 - 2025)

Pulse Biosciences has reported Net Margin over the past 4 years, most recently at 22518.6% for Q3 2025.

  • Quarterly results put Net Margin at 22518.6% for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 64336.05% (changed N/A YoY), and the annual figure for FY2022 was 8357.86%, down 381071.0%.
  • Net Margin for Q3 2025 was 22518.6% at Pulse Biosciences, down from 4665.33% in the prior quarter.
  • Over the last five years, Net Margin for PLSE hit a ceiling of 16450.0% in Q1 2021 and a floor of 22518.6% in Q3 2025.
  • Median Net Margin over the past 3 years was 2488.15% (2021), compared with a mean of 2334.69%.
  • Biggest five-year swings in Net Margin: surged 22730032bps in 2021 and later tumbled -2076825bps in 2022.
  • Pulse Biosciences' Net Margin stood at 1866.34% in 2021, then tumbled by -150bps to 4665.33% in 2022, then crashed by -383bps to 22518.6% in 2025.
  • The last three reported values for Net Margin were 22518.6% (Q3 2025), 4665.33% (Q2 2022), and 4318.25% (Q1 2022) per Business Quant data.